FOLFIRI, FOLFOX4 AND BEVACIZUMAB TREATMENT IN A PATIENT ON MAINTENANCE HEMODIALYSIS WITH ADVANCED RECTAL CANCER SHOWING A SUBMUCOSAL TUMOR-LIKE APPEARANCE

DOI Web Site 1 Citations 21 References

Bibliographic Information

Other Title
  • 血液透析患者に対しＦＯＬＦＩＲＩ療法，Ｂｅｖａｃｉｚｕｍａｂ併用ＦＯＬＦＯＸ４療法を施行した，粘膜下腫瘍様直腸癌の１例

Search this article

Description

A 57-year-old man undergoing maintenance hemodialysis for chronic renal failure was admitted for investigation of the cause of dyschezia. After endoscopic and radiological examinations, low-anterior resection was performed for advanced rectal cancer showing a submucosal tumor-like appearance. Seven months later, elevation of the serum CEA level and multiple lung metastases were found. The patient was administered FOLFIRI therapy (CPT-11 65mg/m2), followed by FOLFOX4 therapy (Oxaliplatin 32mg/m2), FOLFIRI therapy (CPT-11 80mg/m2) and finally, bevacizumab + FOLFOX4 therapy (bevacizumab 5mg/kg, oxaliplatin 85mg/m2), without severe side effects. A colorectal cancer presenting with a submucosal tumor-like appearance is rare and sometimes difficult to diagnose preoperatively. Although no standard adjuvant chemotherapy has been established for renal failure patients with colorectal cancer, we could safely administer the above-mentioned chemotherapies to this patient. Herein, we report this rare tumor and the valuable experience of chemotherapy in a chronic renal failure patient with colorectal cancer.

Journal

Citations (1)*help

See more

References(21)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top